<< Nano Mask signs a three year agreement to distribute Wein Products respirators | Pharma IQ to organize Anti-Infectives Summit in Philadelphia >>
Read in | English | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | Nederlands | Ελληνικά | Русский

Scientists identify potential drug development target for epilepsy seizures

Published on December 10, 2009 at 12:14 AM · No Comments

A team of scientists from The University of Alabama used worms to reel in information that they hope will lead to a greater understanding of cellular mechanisms that may be exploited to treat epilepsy. In a new research report in the journal GENETICS (http://www.genetics.org), the researchers explain how the transparent roundworm, C. elegans, helped them identify key "molecular switches" that control the transport of a molecule (gamma-aminobutyric acid or "GABA") that if manipulated within our cells, might prevent the onset of seizures.

"It is our hope that this work serves to accelerate the path toward the identification of genetic factors that cause a susceptibility to epilepsy," said Guy A. Caldwell, Ph.D., co-author of the study from the Department of Biological Sciences at The University of Alabama in Tuscaloosa. "Simultaneously, this work has the potential to uncover new avenues toward therapeutic development to control or prevent seizures in the future."

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading